FIGURE 9
Tumor genomic mutations (n = 13). Exome sequencing was performed for pretreatment specimens using Tempus (n = 12) and Foundation Medicine (n = 1).

Tumor genomic mutations (n = 13). Exome sequencing was performed for pretreatment specimens using Tempus (n = 12) and Foundation Medicine (n = 1).

Abbreviations: CR, complete response; LN, lymph node; PD, progressive disease; PFS, progressive‐free survival; PR, partial response; Pre‐Tx, pretreatment; SD, stable disease.
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close